Hiroyasu Shimada

2.3k total citations
46 papers, 1.6k citations indexed

About

Hiroyasu Shimada is a scholar working on Molecular Biology, Cancer Research and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Hiroyasu Shimada has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 22 papers in Cancer Research and 9 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Hiroyasu Shimada's work include Carcinogens and Genotoxicity Assessment (21 papers), Effects and risks of endocrine disrupting chemicals (7 papers) and DNA Repair Mechanisms (4 papers). Hiroyasu Shimada is often cited by papers focused on Carcinogens and Genotoxicity Assessment (21 papers), Effects and risks of endocrine disrupting chemicals (7 papers) and DNA Repair Mechanisms (4 papers). Hiroyasu Shimada collaborates with scholars based in Japan, United Kingdom and United States. Hiroyasu Shimada's co-authors include Makoto Hayashi, Toshio Sofuni, Seiichi Sato, Akihiro Wakata, Sakae Kitada, Takumi Awogi, Yoshinori Fujimoto, Bernard Vannier, F. Romagna and Raymond R. Tice and has published in prestigious journals such as Journal of Biological Chemistry, Nutrients and Phytochemistry.

In The Last Decade

Hiroyasu Shimada

45 papers receiving 1.5k citations

Peers

Hiroyasu Shimada

HTM

BIOCH

D. Gatehouse United Kingdom

Amy Liem United States

M.H.L. Green United Kingdom

T. Nohmi Japan

B. Myhr United States

Richard H.C. San United States

J.P. Seiler Switzerland

Mark Hite United States

Elena C. McCoy United States

Jon C. Mirsalis United States

D. Gatehouse United Kingdom

Hiroyasu Shimada

845 ×1.2

473 ×0.7

418 ×1.0

HTM

329 ×1.0

34 ×0.3

BIOCH

Citations per year, relative to Hiroyasu Shimada Hiroyasu Shimada (= 1×) peers D. Gatehouse

Countries citing papers authored by Hiroyasu Shimada

Since Specialization

Citations

This map shows the geographic impact of Hiroyasu Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyasu Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyasu Shimada more than expected).

Fields of papers citing papers by Hiroyasu Shimada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyasu Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyasu Shimada. The network helps show where Hiroyasu Shimada may publish in the future.

Co-authorship network of co-authors of Hiroyasu Shimada

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyasu Shimada. A scholar is included among the top collaborators of Hiroyasu Shimada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyasu Shimada. Hiroyasu Shimada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shimada, Hiroyasu, et al.. (2024). Visceral Fat-Reducing Effect of Novel Dietary Intervention Program: A Randomized Controlled Trial in Japanese Males. Nutrients. 16(18). 3202–3202. 3 indexed citations

Tsukinoki, Keiichi, Tetsuro Yamamoto, Kei’ichiro Iguchi, et al.. (2022). Prevalence of saliva immunoglobulin A antibodies reactive with severe acute respiratory syndrome coronavirus 2 among Japanese people unexposed to the virus. Microbiology and Immunology. 66(8). 403–410. 4 indexed citations

Shimada, Hiroyasu & Sakae Kitada. (2010). Mega assemblages of oligomeric aerolysin-like toxins stabilized by toxin-associating membrane proteins. The Journal of Biochemistry. 149(1). 103–115. 8 indexed citations

Kitada, Sakae, et al.. (2009). Parasporin-2 requires GPI-anchored proteins for the efficient cytocidal action to human hepatoma cells. Toxicology. 264(1-2). 80–88. 27 indexed citations

Abe, Yoshito, Hiroyasu Shimada, & Sakae Kitada. (2007). Raft-targeting and Oligomerization of Parasporin-2, a Bacillus thuringiensis Crystal Protein with Anti-Tumour Activity. The Journal of Biochemistry. 143(2). 269–275. 38 indexed citations

Saeki, Ken‐ichi, et al.. (2000). Clastogenicity of Quinoline Derivatives Tested by Micronucleus Induction in Vivo in the Hepatocytes of Partially Hepatectomized Mice.. Biological and Pharmaceutical Bulletin. 23(2). 219–221. 3 indexed citations

Müller, Lutz, Yasumoto Kikuchi, Gregory S. Probst, et al.. (1999). ICH-Harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact. Mutation Research/Reviews in Mutation Research. 436(3). 195–225. 116 indexed citations

Itoh, Satoru, Miki Miura, Toshiaki Itoh, et al.. (1999). N-Nitrosodi-n-propylamine induces organ specific mutagenesis with specific expression times in lacZ transgenic mice. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 444(2). 309–319. 8 indexed citations

Itoh, Satoru, et al.. (1998). Lack of mutagenicity of levofloxacin in lacZ transgenic mice. Mutagenesis. 13(1). 51–55. 6 indexed citations

10.

Itoh, Satoru, Miki Miura, & Hiroyasu Shimada. (1997). Germ cell mutagenesis in lacZ transgenic mice treated with methyl methanesulfonate. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 388(2-3). 223–228. 7 indexed citations

11.

Yamashita, Hiroshi, et al.. (1996). Analysis of double-stranded RNA for plant virus diagnosis.. 111–114. 2 indexed citations

12.

Sofuni, Toshio, Masamitsu Honma, Makoto Hayashi, et al.. (1996). Detection of in vitro clastogens and spindle poisons by the mouse lymphoma assay using the micro well method: interim report of an international collaborative study. Mutagenesis. 11(4). 349–355. 43 indexed citations

13.

Nakayama, Shouta M.M., et al.. (1995). MUTAGENICITY STUDIES OF IODIXANOL, A NEW NON-IONIC ISOTONIC CONTRAST MEDIUM. The Journal of Toxicological Sciences. 20(SupplementI). 125–131. 1 indexed citations

14.

Clive, D., George Bölcsföldi, Julie Clements, et al.. (1995). Consensus agreement regarding protocol issues discussed during the mouse lymphoma workshop: Portland, Oregon, may 7, 1994. Environmental and Molecular Mutagenesis. 25(2). 165–168. 36 indexed citations

15.

Jayasinghe, Lalith, Hiroyasu Shimada, Noriyuki Hara, & Yoshinori Fujimoto. (1995). Hederagenin glycosides from Pometia eximia. Phytochemistry. 40(3). 891–897. 23 indexed citations

16.

Tice, Raymond R., James T. MacGregor, Diana Anderson, et al.. (1994). Report from the working group on the in vivo mammalian bone marrow chromosomal aberration test. Mutation Research/Environmental Mutagenesis and Related Subjects. 312(3). 305–312. 26 indexed citations

17.

Hayashi, Makoto, Raymond R. Tice, James T. MacGregor, et al.. (1994). In vivo rodent erythrocyte micronucleus assay. Mutation Research/Environmental Mutagenesis and Related Subjects. 312(3). 293–304. 278 indexed citations

18.

Chang‐Claude, Jenny, Hiroyasu Shimada, Núbia Muñóz, et al.. (1993). Micronuclei in esophageal cells of Chinese youths in a high-incidence area for esophageal cancer in China.. PubMed. 1(6). 463–6. 9 indexed citations

19.

Itoh, Satoru, et al.. (1992). 307 In vivo mutagenesis with metal compounds in transgenic mouse. The Journal of Toxicological Sciences. 17(4). 331. 1 indexed citations

20.

Kawamura, Kenji, et al.. (1989). Micronucleus test with potassium chromate(VI) administered intraperitoneally and orally to mice. Mutation Research/Genetic Toxicology. 223(4). 403–406. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact